• Something wrong with this record ?

Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia

GM. Giordano, P. Pezzella, A. Mucci, SF. Austin, A. Erfurth, B. Glenthøj, A. Hofer, J. Hubenak, J. Libiger, I. Melle, MØ. Nielsen, JK. Rybakowski, P. Wojciak, S. Galderisi, G. Sachs

. 2024 ; 15 (-) : 1333711. [pub] 20240131

Status not-indexed Language English Country Switzerland

Document type Journal Article

INTRODUCTION: In this study we assessed the contribution of psychopathology, including the two domains of negative symptoms (motivational deficit and expressive deficit), processing speed as an index of neurocognition, and emotion recognition, as an index of social cognition, to poor functional outcomes in people with schizophrenia. METHODS: The Positive and Negative Syndrome Scale was used to evaluate positive symptoms and disorganization and the Brief Negative Symptom Scale to assess negative symptoms. The Symbol Coding and the Trail Making Test A and B were used to rate processing speed and the Facial Emotion Identification Test to assess emotion recognition. Functional outcome was assessed with the Personal and Social Performance Scale (PSP). Regression analyses were performed to identify predictors of functional outcome. Mediation analyses was used to investigate whether social cognition and negative symptom domains fully or partially mediated the impact of processing speed on functional outcome. RESULTS: One hundred and fifty subjects from 8 different European centers were recruited. Our data showed that the expressive deficit predicted global functioning and together with motivational deficit fully mediated the effects of neurocognition on it. Motivational deficit was a predictor of personal and social functioning and fully mediated neurocognitive impairment effects on the same outcome. Both motivational deficit and neurocognitive impairment predicted socially useful activities, and the emotion recognition domain of social cognition partially mediated the impact of neurocognitive deficits on this outcome. CONCLUSIONS: Our results indicate that pathways to functional outcomes are specific for different domains of real-life functioning and that negative symptoms and social cognition mediate the impact of neurocognitive deficits on different domains of functioning. Our results suggest that both negative symptoms and social cognition should be targeted by psychosocial interventions to enhance the functional impact of neurocognitive remediation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24005918
003      
CZ-PrNML
005      
20240412130902.0
007      
ta
008      
240405e20240131sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fpsyt.2024.1333711 $2 doi
035    __
$a (PubMed)38356912
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Giordano, Giulia M $u Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
245    10
$a Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia / $c GM. Giordano, P. Pezzella, A. Mucci, SF. Austin, A. Erfurth, B. Glenthøj, A. Hofer, J. Hubenak, J. Libiger, I. Melle, MØ. Nielsen, JK. Rybakowski, P. Wojciak, S. Galderisi, G. Sachs
520    9_
$a INTRODUCTION: In this study we assessed the contribution of psychopathology, including the two domains of negative symptoms (motivational deficit and expressive deficit), processing speed as an index of neurocognition, and emotion recognition, as an index of social cognition, to poor functional outcomes in people with schizophrenia. METHODS: The Positive and Negative Syndrome Scale was used to evaluate positive symptoms and disorganization and the Brief Negative Symptom Scale to assess negative symptoms. The Symbol Coding and the Trail Making Test A and B were used to rate processing speed and the Facial Emotion Identification Test to assess emotion recognition. Functional outcome was assessed with the Personal and Social Performance Scale (PSP). Regression analyses were performed to identify predictors of functional outcome. Mediation analyses was used to investigate whether social cognition and negative symptom domains fully or partially mediated the impact of processing speed on functional outcome. RESULTS: One hundred and fifty subjects from 8 different European centers were recruited. Our data showed that the expressive deficit predicted global functioning and together with motivational deficit fully mediated the effects of neurocognition on it. Motivational deficit was a predictor of personal and social functioning and fully mediated neurocognitive impairment effects on the same outcome. Both motivational deficit and neurocognitive impairment predicted socially useful activities, and the emotion recognition domain of social cognition partially mediated the impact of neurocognitive deficits on this outcome. CONCLUSIONS: Our results indicate that pathways to functional outcomes are specific for different domains of real-life functioning and that negative symptoms and social cognition mediate the impact of neurocognitive deficits on different domains of functioning. Our results suggest that both negative symptoms and social cognition should be targeted by psychosocial interventions to enhance the functional impact of neurocognitive remediation.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pezzella, Pasquale $u Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
700    1_
$a Mucci, Armida $u Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
700    1_
$a Austin, Stephen F $u Psychiatric Research Unit, Region Zealand Psychiatry, Slagelse, Denmark
700    1_
$a Erfurth, Andreas $u 6th Psychiatric Department, Otto-Wagner-Spital, Vienna, Austria
700    1_
$a Glenthøj, Birte $u Center for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Glostrup, Denmark $u Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
700    1_
$a Hofer, Alex $u Medical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, Austria
700    1_
$a Hubenak, Jan $u Department of Psychiatry, Charles University, Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czechia
700    1_
$a Libiger, Jan $u Department of Psychiatry, Charles University, Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czechia
700    1_
$a Melle, Ingrid $u NORMENT Centre, Institute of Clinical Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway
700    1_
$a Nielsen, Mette Ø $u Center for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Glostrup, Denmark $u Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
700    1_
$a Rybakowski, Janusz K $u Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
700    1_
$a Wojciak, Pawel $u Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
700    1_
$a Galderisi, Silvana $u Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
700    1_
$a Sachs, Gabriele $u Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
773    0_
$w MED00174602 $t Frontiers in psychiatry $x 1664-0640 $g Roč. 15 (20240131), s. 1333711
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38356912 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240412130855 $b ABA008
999    __
$a ok $b bmc $g 2076068 $s 1215680
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1333711 $e 20240131 $i 1664-0640 $m Frontiers in psychiatry $n Front Psychiatry $x MED00174602
LZP    __
$a Pubmed-20240405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...